DK1419177T3 - Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin - Google Patents
Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicinInfo
- Publication number
- DK1419177T3 DK1419177T3 DK02754557T DK02754557T DK1419177T3 DK 1419177 T3 DK1419177 T3 DK 1419177T3 DK 02754557 T DK02754557 T DK 02754557T DK 02754557 T DK02754557 T DK 02754557T DK 1419177 T3 DK1419177 T3 DK 1419177T3
- Authority
- DK
- Denmark
- Prior art keywords
- globulin
- medicine
- scale production
- purification process
- product
- Prior art date
Links
- 102000050760 Vitamin D-binding protein Human genes 0.000 title abstract 9
- 101710179590 Vitamin D-binding protein Proteins 0.000 title abstract 9
- 238000000746 purification Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 238000011031 large-scale manufacturing process Methods 0.000 title abstract 2
- 239000000047 product Substances 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000003022 colostrum Anatomy 0.000 abstract 1
- 235000021277 colostrum Nutrition 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000004255 ion exchange chromatography Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101217 | 2001-08-14 | ||
| PCT/DK2002/000531 WO2003016348A2 (en) | 2001-08-14 | 2002-08-12 | A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1419177T3 true DK1419177T3 (da) | 2008-08-25 |
Family
ID=8160667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02754557T DK1419177T3 (da) | 2001-08-14 | 2002-08-12 | Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1419177B1 (enExample) |
| JP (1) | JP2005508892A (enExample) |
| AT (1) | ATE393780T1 (enExample) |
| AU (1) | AU2002321012B2 (enExample) |
| CA (1) | CA2456843A1 (enExample) |
| DE (1) | DE60226327T2 (enExample) |
| DK (1) | DK1419177T3 (enExample) |
| ES (1) | ES2305272T3 (enExample) |
| WO (1) | WO2003016348A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1778301A2 (en) * | 2004-06-29 | 2007-05-02 | Reliance Life Sciences Pvt., Ltd. | Process for improvement of virus-safe biological fluids |
| CN100354301C (zh) * | 2005-10-13 | 2007-12-12 | 南京工业大学 | 化学合成多肽的新型大规模分离制备技术 |
| US8129139B2 (en) | 2009-07-13 | 2012-03-06 | Allergan, Inc. | Process for obtaining botulinum neurotoxin |
| SG10201503899SA (en) * | 2010-05-18 | 2015-06-29 | Abbvie Inc | Apparatus And Process Of Purification Of Proteins |
| JP5860401B2 (ja) | 2010-09-03 | 2016-02-16 | 森田薬品工業株式会社 | 新規Ｇｃグロブリンガラクトース脱糖体の製造方法 |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| PL3081221T3 (pl) | 2013-12-13 | 2021-12-27 | Saisei Pharma Co., Ltd. | Kompozycja farmaceutyczna zawierająca produkt obróbki enzymatycznej siary bydlęcej |
| CN111632167B (zh) * | 2014-04-15 | 2021-12-28 | 勃林格殷格翰国际公司 | 在制造生物制品期间连续灭活病毒的方法、装置和系统 |
| PL3290043T3 (pl) * | 2015-06-01 | 2023-07-03 | Saisei Pharma Co., Ltd. | Produkt mleczny poddany obróbce enzymatycznej, sposób jego wytwarzania, kompozycja i produkt |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5177002A (en) * | 1989-11-20 | 1993-01-05 | Nobuto Yamamoto | In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor |
| ES2124702T3 (es) * | 1990-04-11 | 1999-02-16 | Brigham & Womens Hospital | Usos terapeuticos de compuestos que se unen a actina. |
| US6268478B1 (en) * | 1996-02-12 | 2001-07-31 | Cedars-Sinai Medical Center | Intracellular vitamin D binding protein |
-
2002
- 2002-08-12 CA CA002456843A patent/CA2456843A1/en not_active Abandoned
- 2002-08-12 AU AU2002321012A patent/AU2002321012B2/en not_active Ceased
- 2002-08-12 WO PCT/DK2002/000531 patent/WO2003016348A2/en not_active Ceased
- 2002-08-12 ES ES02754557T patent/ES2305272T3/es not_active Expired - Lifetime
- 2002-08-12 AT AT02754557T patent/ATE393780T1/de not_active IP Right Cessation
- 2002-08-12 DK DK02754557T patent/DK1419177T3/da active
- 2002-08-12 DE DE60226327T patent/DE60226327T2/de not_active Expired - Fee Related
- 2002-08-12 EP EP02754557A patent/EP1419177B1/en not_active Expired - Lifetime
- 2002-08-12 JP JP2003521270A patent/JP2005508892A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003016348A3 (en) | 2004-03-04 |
| ES2305272T3 (es) | 2008-11-01 |
| DE60226327T2 (de) | 2009-07-09 |
| EP1419177B1 (en) | 2008-04-30 |
| EP1419177A2 (en) | 2004-05-19 |
| DE60226327D1 (de) | 2008-06-12 |
| JP2005508892A (ja) | 2005-04-07 |
| WO2003016348A2 (en) | 2003-02-27 |
| CA2456843A1 (en) | 2003-02-27 |
| ATE393780T1 (de) | 2008-05-15 |
| AU2002321012B2 (en) | 2008-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Conceição et al. | Safety criteria to start early mobilization in intensive care units. Systematic review | |
| Tricarico et al. | The relationship between ozone and human blood in the course of a well-controlled, mild, and transitory oxidative eustress | |
| EP1692516A4 (en) | THERAPY PROCESS | |
| Ma et al. | Exercise therapy augments the ischemia-induced proangiogenic state and results in sustained improvement after stroke | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| ATE393780T1 (de) | Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin | |
| Rothenburg et al. | COVID-19 antibody donation using immunoadsorption: report of two cases | |
| Zhang et al. | Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF | |
| CN108347886A (zh) | 具降低疼痛功效的猴头萜、猴头菇菌丝体活性物质、其制备方法、及含其的医药组合物 | |
| Bernini et al. | NEURODEGENERATIVE DISEASES AND COGNITIVE INTERVENTIONS: WHAT IS THE FUTURE? | |
| CN202776947U (zh) | 一种带储液瓶的刮板装置 | |
| DK2037949T3 (da) | Fremgangsmåde til at fremstille et "transfer-faktor" medikament | |
| CN104560925A (zh) | 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法 | |
| CN103789291A (zh) | 一种重组大肠杆菌发酵液中分离纯化重组人尿激酶原的制备工艺 | |
| Sarkova et al. | EAV and Gemmotherapy-Medicine for the Next Millennium?(technique as a means to link eastern and western medicine) | |
| Habib et al. | Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001) | |
| CN101204577A (zh) | 一种a型肉毒毒素结晶复合物的制备方法 | |
| RU2489172C1 (ru) | Способ проведения лечебного дискретного плазмафереза с экстракарпоральной модификацией эритроцитов и лейкоцитов индукторами интерферона, антиоксидантами и протекторами клеток | |
| Jabraeili et al. | The Effects of Field massage on urine cortisol level in premature infants: clinical trial | |
| Tsay et al. | When holistic care touches the sole | |
| RU2115125C1 (ru) | Способ защиты лимфоидных клеток крови человека от вич | |
| Ivanova et al. | Therapeutic benefit of PRP-therapy in treatment of atrophic vaginitis and vulva lichen sclerosus | |
| Sollmann | THE THERAPEUTIC RESEARCH COMMITTEE: OF THE COUNCIL ON PHARMACY AND CHEMISTRY OF THE AMERICAN MEDICAL ASSOCIATION | |
| Nahler | biorepository | |
| Nahler | biologic equivalent |